Results 1 to 10 of about 2,127,148 (291)

The disparity of platelet factor 4 and platelets in individuals of different ages [PDF]

open access: yesHeliyon
The aging process profoundly impacts the systemic milieu, with specific blood-borne factors playing critical roles in its regulation. Platelet Factor 4 (PF4), released by platelets, has emerged as a novel blood-borne factor that contributes to the ...
Ruopeng Weng   +8 more
doaj   +4 more sources

Platelet factor 4 in cognitive, immune and hematopoietic aging: emerging evidence and translational challenges [PDF]

open access: yesFrontiers in Immunology
Platelet Factor 4 (PF4) is a CXC chemokine abundantly sequestered within platelet α-granules. Its modulatory roles in age-related dysfunction across cognitive, immune, and hematopoietic systems have garnered increasing research attention in recent years.
Yingying Guo   +5 more
doaj   +2 more sources

In platelet single donor apheresis, platelet factor 4 levels correlated with donor’s age and decreased during storage [PDF]

open access: yesScientific Reports
The human population is ageing worldwide. The World Health Organization estimated that the world’s population of people aged 60 years and older will increase to at least 30%, coinciding with a growing frequency of cognitive and cardiovascular disease ...
Anne Claire Duchez   +7 more
doaj   +2 more sources

Microfluidic Electrochemical Biosensor for the Detection of Platelet Factor 4 Antibody‐Mediated Thrombotic Disorders [PDF]

open access: yesAdvanced Science
Vaccine‐induced immune thrombotic thrombocytopenia (VITT) is a new disorder that emerged in the wake of coronavirus disease 2019 (COVID‐19) vaccination.
Diana F. Cedillo‐Alcantar   +8 more
doaj   +2 more sources

Anti‐platelet factor 4/heparin antibodies in patients with Hantaan virus infection [PDF]

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2022
Background Hemorrhagic fever with renal syndrome (HFRS) induced by Hantaan virus infection and heparin‐induced thrombocytopenia (HIT) are associated with symptoms such as thrombocytopenia and thrombosis.
Meng Wang   +10 more
doaj   +2 more sources

Platelet factor 4 and stromal cell-derived factor are novel prognostic biomarkers for cerebral vasospasm and mortality after subarachnoid hemorrhage [PDF]

open access: yesScientific Reports
Aneurysmal subarachnoid hemorrhage (aSAH) is a life-threatening condition associated with high rates of morbidity and mortality, mainly due to post-hemorrhagic complications such as cerebral vasospasm (CVS) and delayed cerebral ischemia (DCI).
Dilaware Khan   +5 more
doaj   +2 more sources

Molecular architecture and platelet-activating properties of small immune complexes assembled on heparin and platelet factor 4 [PDF]

open access: yesCommunications Biology
Heparin-induced thrombocytopenia (HIT) is an adverse reaction to heparin leading to a reduction in circulating platelets with an increased risk of thrombosis.
Yang Yang   +7 more
doaj   +2 more sources

Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination

open access: yesNew England Journal of Medicine, 2021
Background The mainstay of control of the coronavirus disease 2019 (Covid-19) pandemic is vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
M. Scully   +9 more
semanticscholar   +1 more source

Galectin-1 and platelet factor 4 (CXCL4) induce complementary platelet responses in vitro.

open access: yesPLoS ONE, 2021
Galectin-1 (gal-1) is a carbohydrate-binding lectin with important functions in angiogenesis, immune response, hemostasis and inflammation. Comparable functions are exerted by platelet factor 4 (CXCL4), a chemokine stored in the α-granules of platelets ...
Annemiek Dickhout   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy